[Systemic inflammatory response syndrome: new concepts]
- PMID: 11381800
[Systemic inflammatory response syndrome: new concepts]
Abstract
Systemic inflammatory response syndrome is secondary to several insults whose purpose is to limit and reverse the injury. The outcome and intensity of the inflammatory response is determined by injury extension and balance between inflammatory and compensatory antiinflammatory responses. The interaction of the several soluble and cellular mediators of inflammatory and antiinflammatory responses determine the next evolutive phases: a) local inflammatory response; b) systemic inflammatory response; c) massive systemic inflammatory response; d) immunologic paralysis; and e) immune dissonance. If the last three phases do not control, cell damage can be amplified and thus perpetuating the infectious process and leading the patient to multiple organ dysfunction. Gamma interferon and steroids as modulators of the inflammatory response, in stages of paralysis and immune dissonance has been studied in clinical and experimental trials with promising results, but more studies to are needed validate their usefulness.
Similar articles
-
Compartmentalization of the inflammatory response in sepsis and SIRS.J Endotoxin Res. 2006;12(3):151-70. doi: 10.1179/096805106X102246. J Endotoxin Res. 2006. PMID: 16719987 Review.
-
Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis.New Horiz. 1998 May;6(2 Suppl):S97-102. New Horiz. 1998. PMID: 9654318 Review.
-
Pathophysiology of polytrauma.Injury. 2005 Jun;36(6):691-709. doi: 10.1016/j.injury.2004.12.037. Injury. 2005. PMID: 15910820 Review.
-
Systemic inflammation after trauma.Injury. 2007 Dec;38(12):1336-45. doi: 10.1016/j.injury.2007.10.003. Epub 2007 Nov 28. Injury. 2007. PMID: 18048040 Review.
-
[Special therapeutic approaches for interrupting the cascade--from systemic inflammatory response syndrome to multiple organ failure].Langenbecks Arch Chir Suppl Kongressbd. 1998;115:615-8. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 9931689 German.
Cited by
-
Systemic Inflammatory Markers and Clinical Outcomes of Open versus Biportal Endoscopic Transforaminal Lumbar Interbody Fusion.Ther Clin Risk Manag. 2024 May 7;20:249-259. doi: 10.2147/TCRM.S447394. eCollection 2024. Ther Clin Risk Manag. 2024. PMID: 38736989 Free PMC article.